Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/07/12
End: 11/16/15
Due: 11/16/16
Phase: N/A
Priority: Normal
Start: 07/18/12
End: 02/21/17
Due: 02/21/18
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002 | NCT01608711 | Agensys, Inc. | user2@example.com | None | 2012-08-07 | 2015-11-16 | 2016-11-16 | - | - | 2025-07-14 |
| A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology | NCT01672775 | Agensys, Inc. | user2@example.com | None | 2012-07-18 | 2017-02-21 | 2018-02-21 | - | - | 2025-07-14 |